**Author details**

Jeffrey G. Marx1 and Morgan P. Lorio2 \*

1 Cerapedics Inc., Westminster, CO, USA

2 Advanced Orthopedics and Pain Management, Altamonte Springs, FL, USA

\*Address all correspondence to: mloriomd@gmail.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**59**

*Class III Spine Grafts*

**References**

1970;**68**:279-293

2017;**41**:1065

*DOI: http://dx.doi.org/10.5772/intechopen.87706*

in sheep spinal anterior interbody fusion. Spine (Phila Pa 1976). 2002;**27**(6):567-575

[9] Boden SD, Martin GJ Jr, Horton WC, Truss TL, Sandhu HS. Laparoscopic anterior spina arthrodesis with rhBMP-2 in a titanium interbody threaded cage. Journal of Spinal Disorders. 1998;**11**(2):95-101

[10] Boden SD, Martin GJ Jr,

1999;**24**(12):1179-1185

2002;**27**(23):2662-2673

[13] Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, et al. BMP-2

2002;**84-A**(12):2123-2134

evaluation in surgery for tibial trauma (BESTT) study group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. The Journal of Bone and Joint Surgery. American Volume.

[14] Boyne PJ, Lilly LC, et al. De novo bone induction by recombinant human morphogenetic protein-2 (rhBMP-2)

Morone MA, Ugbo JL, Moskovitz PA. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/

hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine (Phila Pa 1976).

[11] Burkus JK et al. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. Journal of Spinal Disorders. 2002;**15**(5):337-349

[12] Boden SD, Kang J, Sandhu HD, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial 2002 Volvo Award in clinical studies. Spine.

[1] Urist MR. Bone: Formation by autoinduction. Science. 1995;**150**(3698):893-899

[2] Urist MR, Jurist JM Jr, Dubuc FL, Strates BS. Quantitation of new bone formation in intramuscular implants of bone matrix in rabbits. Clinical Orthopaedics and Related Research.

[3] Grgurevic L, Pecina M, Vukicevic S. Marshall R. Urist and the discovery of bone morphogenetic proteins. International Orthopaedics (SICOT).

[4] Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP, et al. Purification and characterization of other distinct bone-inducing factors. Proceedings of the National Academy of Sciences of the United States of America. 1988;**85**(24):9484-9488

[5] Sampath TK, Reddi AH. Dissociative

extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proceedings of the National Academy of Sciences of the United States of America. 1981;**78**(12):7599-7603

[6] Simic P, Vukecevic S. Bone morphogenetic proteins: From developmental signals to tissue regeneration. Conference on bone morphogenetic proteins. EMBO Reports. 2008;**8**(4):327-331

[7] Sandu HS, Kanim MA, Kabo JM, Toth JM, Zeegen EN, Liu D, et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine.

[8] Sandhu HS, Toth JM, Diwan AD, Seim HB 3rd, Kanim LE, Kabo JM, et al. Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone

1996;**21**:2115-2122
